1. A vasopressin analogue in treatment of diabetes insipidus. Issue 6 (June 1974) Authors: Kauli, Rivka; Laron, Zvi Journal: Archives of disease in childhood Issue: Volume 49:Issue 6(1974) Page Start: 482 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. An Attenuation in the Incidence of Early Childhood Diabetes Correlates With Introduction of Rotavirus Vaccination in Israel. (1st September 2020) Authors: Blumenfeld, Orit; Hampe, Christiane S; Shulman, Lester M; Chen, Roni; Laron, Zvi Journal: Journal of infectious diseases Issue: Volume 223:Number 7(2021) Page Start: 1305 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Changes in plasma amino acids metabolites, caused by long-term IGF-I deficiency, are reversed by IGF-I treatment – A pilot study. (June 2020) Authors: Barazani, Chen; Werner, Haim; Laron, Zvi Journal: Growth hormone & IGF research Issue: Volume 52(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Differential expression of IGFBPs in Laron syndrome-derived lymphoblastoid cell lines: Potential correlation with reduced cancer incidence. (April 2018) Authors: Somri, Lina; Sarfstein, Rive; Lapkina-Gendler, Lena; Nagaraj, Karthik; Laron, Zvi; Bach, Leon A.; Werner, Haim Journal: Growth hormone & IGF research Issue: Volume 39(2018) Page Start: 6 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Emerging treatment options for patients with Laron syndrome. (July 2014) Authors: Laron, Zvi Journal: Expert opinion on orphan drugs Issue: Volume 2:Number 7(2014:Jul.) Page Start: 681 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Epilogue: The future of Laron syndrome — The need for changes. (June 2016) Authors: Laron, Zvi Journal: Growth hormone & IGF research Issue: Volume 28(2016) Page Start: 79 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Erratum to 'Identification of nephronectin as a new target for IGF1 action' [Eur J Canc 141 (2020) Pages 115–127]. (May 2021) Authors: Sarfstein, Rive; Lapkina-Gendler, Lena; Nagaraj, Karthik; Laron, Zvi; Werner, Haim Journal: European journal of cancer Issue: Volume 148(2021) Page Start: 453 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Fifty seven years of follow-up of the Israeli cohort of Laron Syndrome patients—From discovery to treatment. (June 2016) Authors: Laron, Zvi; Kauli, Rivka Journal: Growth hormone & IGF research Issue: Volume 28(2016) Page Start: 53 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Growth, development, puberty and adult height before and during treatment in children with congenital isolated growth hormone deficiency. Issue 4 (August 2015) Authors: Smuel, Keren; Kauli, Rivka; Lilos, Pearl; Laron, Zvi Journal: Growth hormone & IGF research Issue: Volume 25:Issue 4(2015:Aug.) Page Start: 182 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Growth, development, puberty and adult height of patients with congenital multiple pituitary hormone deficiencies. (April 2016) Authors: Haim-Pinhas, Hadar; Kauli, Rivka; Lilos, Pearl; Laron, Zvi Journal: Growth hormone & IGF research Issue: Volume 27(2016) Page Start: 46 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗